Autres langues Disc Medicine, Inc.

Actions

IRON

US2546041011

Temps réel estimé Cboe BZX Autres places de cotation 21:56:09 07/06/2024			Varia. 5j.	Varia. 1 janv.
38,8 ^USD	+6,43 %		+17,32 %	-31,04 %

09/05	Disc Medicine, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
08/04	DISC MEDICINE, INC. : Stifel Nicolaus reste à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Disc Medicine to Participate in the Jefferies Global Healthcare Conference	30/05
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress	14/05
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference	13/05
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference	13/05
Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update	09/05
North American Morning Briefing : Stocks Seen -2-	02/04
Top Midday Decliners	01/04
Disc Medicine Trial of Light Sensitivity Treatment Achieves Primary Goal, But Misses Secondary Endpoint; Wedbush Cuts Price Target -- Shares Plunge	01/04
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)	01/04
Disc Medicine, Inc. Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Porphyria	01/04
Disc Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	21/03
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024	06/03
Disc Medicine Names Pamela Stephenson as Chief Commercial Officer	26/02
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer	26/02
Disc Medicine, Inc. Appoints Pamela Stephenson as Chief Commercial Officer	26/02
Disc Medicine Says FDA Grants Fast Track Designation for Investigational Treatment of Chronic Kidney Disease, Anemia	20/02
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease	20/02
Disc Medicine Inc Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease	20/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Disc Medicine, Inc.

Actions

IRON

US2546041011

Autres langues

Filtres